Perelman School of Medicine

Penn Researchers Explain How Ends of Chromosomes Are Maintained for Cancer Cell Immortality

Maintaining the ends of chromosomes, called telomeres, is a requisite feature of cells that are able to continuously divide and also a hallmark of human cancer.

Penn Researchers Describe New Cancer Drug Target Involving Lipid Chemical Messengers

More than half of human cancers have abnormally upregulated chemical signals related to lipid metabolism, yet how these signals are controlled during tumor formation is not fully understood.

Penn Study: Exercise Boosts Tumor-fighting Ability of Chemotherapy

Study after study has proven it true: exercise is good for you. But new research from University of Pennsylvania scientists suggests that exercise may have an added benefit for cancer patients undergoing chemotherapy.

Penn Muscle Institute Biologists Receive $9 Million to Research Cellular Motors

Researchers in the Pennsylvania Muscle Institute (PMI), based at the Perelman School of Medicine at the University of Pennsylvania have received $9 million over the next five years from the National Institute of General Medical Sciences to investigate the biology of cellular motors.

Penn Medicine and Wistar Receive $12 Million NCI Melanoma Grant to Help Fast Track Lab Discoveries into Treatments

Penn Medicine and The Wistar Institute have been awarded a prestigious $12.1 million SPORE grant from the National Cancer Institute.

Child Abuse Charges and Adrian Peterson

Note for TV and radio: The University of Pennsylvania has an on-campus ISDN line and satellite uplink facility with live-shot capability.Expert:Debra Schilling Wolfe

Penn Medicine Study Reveals Profile of Patients Most Likely to Delay Hospice Enrollment Until Final Days of Life

One in six cancer patients enroll in hospice only during their last three days of life, according to a new study from a team from the Perelman School of Medicine at the University of Pennsylvania.

Center for Advanced Cellular Therapeutics to Rise on Penn Medicine Campus

The University of Pennsylvania today reached an important milestone in its alliance with Novartis as it unveiled plans for the construction of a first-of-its-kind Center for Advanced Cellular Therapeutics (CACT) on the Penn Medicine campus in Philadelphia.

Penn Medicine Study Reveals Profile of Patients Most Likely to Delay Hospice Enrollment Until Final Days of Life

One in six cancer patients enroll in hospice only during their last three days of life, according to a new study from a team from the Perelman School of Medicine at the University of Pennsylvania.

Penn Medicine: Zebrafish Model of a Learning and Memory Disorder Shows Better Way to Target Treatment

Using a zebrafish model of a human genetic disease called neurofibromatosis (NF1), a team from the Perelman School of Medicine at the University of Pennsylvania has found that the learning and memory components of the disorder are distinct features that will likely need different treatment approaches.

Filters

Penn Researchers Explain How Ends of Chromosomes Are Maintained for Cancer Cell Immortality

Penn Researchers Describe New Cancer Drug Target Involving Lipid Chemical Messengers

Penn Study: Exercise Boosts Tumor-fighting Ability of Chemotherapy

Penn Muscle Institute Biologists Receive $9 Million to Research Cellular Motors

Penn Medicine and Wistar Receive $12 Million NCI Melanoma Grant to Help Fast Track Lab Discoveries into Treatments

Child Abuse Charges and Adrian Peterson

Penn Medicine Study Reveals Profile of Patients Most Likely to Delay Hospice Enrollment Until Final Days of Life

Center for Advanced Cellular Therapeutics to Rise on Penn Medicine Campus

Penn Medicine Study Reveals Profile of Patients Most Likely to Delay Hospice Enrollment Until Final Days of Life

Penn Medicine: Zebrafish Model of a Learning and Memory Disorder Shows Better Way to Target Treatment